...
首页> 外文期刊>VITAE : Academia Biomédica Digital >Use of botulinum toxin type A in patients with spasticity after Cerebral Vascular Disease (CVD)
【24h】

Use of botulinum toxin type A in patients with spasticity after Cerebral Vascular Disease (CVD)

机译:A型肉毒毒素在脑血管病(CVD)痉挛患者中的使用

获取原文
           

摘要

A longitudinal study was conducted to assess functional capacity in a group of patients with spasticity post Cerebral Vascular Disease (CVD) receiving rehabilitation treatment and botulinum toxin type A, treated at the Spasticity Clinic of “Dr. Alejandro Rhode” Rehabilitation National Center, during the period October 2008 - September 2009. Each patient was evaluated at baseline and after treatment (a month and a half to three months), by survey, clinical evaluation and Functional Independence scale (FIM). 21 patients, 5 females (23.8%) and 16 men (76.2%) aged 27 to 82 years were evaluated. Of an average of 47 points on the FIM scale before the dose of toxin, the average value up to 74 points in month and a half and to 105 after 3 months. In conclusion, we demonstrated an improvement in functional capacity of patients with spasticity post-CVD after rehabilitation treatment and application of botulinum toxin.
机译:进行了一项纵向研究,以评估一组接受康复治疗和A型肉毒毒素治疗的脑血管病(CVD)后痉挛患者的功能能力,这些患者在“ Dr.亚历杭德罗·罗德(Alejandro Rhode)国家康复中心,于2008年10月至2009年9月。通过调查,临床评估和功能独立性量表(FIM)对每位患者在基线和治疗后(一个半月至三个月)进行评估。评估21例患者,其中5例女性(23.8%)和16例男性(76.2%)年龄在27至82岁之间。在服用毒素之前,FIM评分平均为47分,其中一个半月的平均值最高为74分,三个月后平均值为105分。总之,我们证明了康复治疗和应用肉毒杆菌毒素后CVD后痉挛的患者的功能增强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号